.
UPMC Cancer Centers, Working in Tandem with the University of Pittsburgh Cancer Institute, Pittsburgh Pennsylvania USA UPMC Cancer Centers, Working in Tandem with the University of Pittsburgh Cancer Institute, Pittsburgh Pennsylvania USA

About Us | News | Jobs | Giving | Volunteer | Contact Us

Search

Prostate Cancer

Partin Coefficient Table III: PSA = 10.1 – 20.0 ng/ml

This table shows the probability of having each of the four pathologic stages of prostate cancer based on Gleason score, clinical stage and a PSA level between 10.1 and 20.0 ng/ml.


Examples

  • A man with a PSA level of 13.3 ng/ml, a Gleason score of 3 and a clinical stage of T1c has a 75% chance of having organ-confined disease.

  • A man with a PSA level of 18.7 ng/ml, a Gleason score of 6 and a clinical stage of T2c has a 9% chance of seminal vesicle involvement.


PSA = 10.1 – 20.0 ng/ml
Probability of Pathologic Stage (%)
   
Clinical Stage
Gleason score
Pathologic stage

T1a

T1b

T1c

T2a

T2b

T2c

T3a

2-4
Organ-confined disease

Established capsular penetration

Seminal
vesicle involvement

Lymph node involvement



76



20



2


0



58



36



4


2



75



22



2


0



60



35



4


1



48



43



7


1



53



37



8


1















5
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement



61



33



3


3



40



50



5


5



60



35



3


1



43



50



5


2



32



57



8


4



36



51



9


4



18



59



15


7

6
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement

















33



49



4


13



55



38



4


3



38



52



5


4



26



57



7


10



31



50



9


10



14



54



14


18

7
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement



33



38



8


18



17



46



11


24



35



45



12


8



22



55



14


9



13



51



18


17



15



45



22


18



6



40



28


26

8-10
Organ-confined disease

Established capsular penetration

Seminal vesicle involvement

Lymph node involvement

















9



33



15


40



23



40



20


16



14



46



22


17



7



38



25


29



8



33



30


29



3



26



34


37

… lack of sufficient data to calculate probability

Reference: Partin AW, Kattan MW, Subong EN, Walsh PC, et al. Combination of prostate-specific antigen, clinical stage and Gleason score to predict pathological stage of localized prostate cancer: A multi-institutional update. JAMA 1997;277:1445-1451. Copyrighted 1997, American Medical Association. Reprinted with permission.



About This Web Site | Give Us Your Feedback | Privacy Statement | Disclaimer | Site Statistics | Informatics Web Resources

© UPMC, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
412-647-2811 | PCI-INFO@upmc.edu |
Designed and maintained by the Department of Biomedical Informatics
Send questions and comments to UPCIwebupdates@upmc.edu